X
Record #51463

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route

Publisher
MDPI
Original paper date
Jun 29, 2020
Institution
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia · Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia · Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt · Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia · Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia · Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia · Oasi Research Institute—IRCCS, Via Conte Ruggero, 73, 94018 Troina (EN), Italy · Department of Drug Sciences, University of Catania, 95125 Catania, Italy · Ibn Sina National College for Medical Studies, Clinical Pharmacy Department, Jeddah 22421, Saudi Arabia · 1Ibn Sina National College for Medical Studies, Jeddah 22421, Saudi Arabia · Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Open access
No
Article type
Research Article
Broad categories
(HSC) Medicine - Drug Design(HSC) Medicine - Neurology(PHY) Nanotechnology
Citation lifecycle

How this paper is being cited

Pre-retraction
4
Same day
1
Post-retraction
1
% post-retraction
16.7%
~1.1 citations/yr before retraction · ~0.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse